Humanigen seeks EUA from USFDA for Lenzilumab to treat COVID-19
This EUA application follows positive results from the LIVE-AIR Phase 3 clinical trial evaluating the ability of lenzilumab to…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.